s6y RICE II PHILIP M 4

RICE II PHILIP M 4, filed Feb 9, 2018: PRIMARY DOCUMENT

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
RICE II PHILIP M

(Last) (First) (Middle)
29139 NORTHWESTERN HWY SUITE 477

(Street)
SOUTHFIELD MI 48034-1006

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zivo Bioscience, Inc. [ ZIVO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/04/2013
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Purchase Warrant $0.12 01/04/2013 A 50,000 01/04/2013 01/04/2016 Common Stock 50,000 (2) 0(1) D
Common Stock Purchase Warrant $0.25 04/01/2013 A 50,000 04/01/2013 04/01/2018 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.25 04/30/2013 A 557,000 04/30/2013 04/30/2018 Common Stock 557,000 (2) 557,000 D
Common Stock Purchase Warrant $0.25 08/10/2013 A 50,000 08/10/2013 08/10/2018 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.25 11/18/2013 A 50,000 11/18/2013 11/18/2018 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.38 01/04/2014 A 50,000 01/04/2014 01/04/2017 Common Stock 50,000 (2) 0(1) D
Common Stock Purchase Warrant $0.17 03/31/2014 A 50,000 03/31/2014 03/31/2019 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.19 05/14/2014 A 50,000 05/14/2014 05/14/2019 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.14 08/14/2014 A 50,000 08/14/2014 08/14/2019 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.09 11/14/2014 A 50,000 11/14/2014 11/14/2019 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.085 04/06/2015 A 50,000 04/06/2015 04/06/2020 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.088 05/13/2015 A 50,000 05/13/2015 05/13/2020 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.12 08/13/2015 A 50,000 08/13/2015 08/13/2020 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.1 09/10/2015 A 250,000 09/10/2015 09/10/2020 Common Stock 250,000 (2) 250,000 D
Common Stock Purchase Warrant $0.08 11/13/2015 A 50,000 11/13/2015 08/13/2020 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.08 03/29/2016 A 50,000 03/29/2016 03/29/2021 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.08 05/13/2016 A 50,000 05/13/2016 05/13/2021 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.08 08/12/2016 A 50,000 08/12/2016 08/12/2021 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.05 09/10/2016 A 250,000 09/10/2016 09/10/2021 Common Stock 250,000 (2) 250,000 D
Common Stock Purchase Warrant $0.08 11/14/2016 A 50,000 11/14/2016 11/14/2021 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.08 03/31/2017 A 50,000 03/31/2017 03/31/2022 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.09 05/12/2017 A 50,000 05/12/2017 05/12/2022 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.06 08/13/2017 A 50,000 08/13/2017 08/13/2022 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.07 09/11/2017 A 500,000 09/11/2017 09/11/2022 Common Stock 500,000 (2) 500,000 D
Common Stock Purchase Warrant $0.07 10/19/2017 A 50,000 10/19/2017 10/19/2022 Common Stock 50,000 (2) 50,000 D
Common Stock Purchase Warrant $0.08 11/08/2017 A 6,000,000 11/08/2017 11/08/2022 Common Stock 6,000,000 (2) 6,000,000 D
Explanation of Responses:
1. These warrants have expired.
2. The warrants were issued to the reporting person as compensation for acting as a director.
/s/ Philip M. Rice II 02/09/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.